What Is GHK Copper Peptide Same as GHK-Cu? (Explained)

What Is GHK Copper Peptide Same as GHK-Cu? (Explained)

Research labs ordering peptides for regenerative studies often ask for 'GHK Copper Peptide' thinking it differs from 'GHK-Cu' listed in supplier catalogs. The confusion wastes procurement cycles and delays experiments. Especially when institutions require exact compound names for regulatory documentation. Here's what matters: they're the same tripeptide-copper complex, just labeled differently depending on whether the supplier uses the full peptide name or the abbreviated chemical notation.

We've processed hundreds of research orders at Real Peptides, and naming variation is the single most common point of confusion before first-time purchases. The gap between understanding nomenclature and ordering the right compound comes down to three things most catalogs never clarify upfront.

What is GHK Copper Peptide same as GHK-Cu?

GHK Copper Peptide and GHK-Cu are identical. Both refer to the tripeptide glycyl-L-histidyl-L-lysine complexed with a copper(II) ion. The 'GHK' abbreviation represents the three amino acids (glycine-histidine-lysine) in single-letter code, while 'Copper Peptide' describes the copper ion bound to the tripeptide. The compound has a molecular formula of C14H24CuN6O4 and a molecular weight of approximately 404 Da, regardless of which name appears on the label.

Yes, GHK Copper Peptide is the same as GHK-Cu. But the naming inconsistency creates procurement confusion that delays research timelines unnecessarily. 'GHK-Cu' is the abbreviated chemical notation favored in peer-reviewed publications and synthesis protocols, while 'GHK Copper Peptide' appears more frequently in commercial product listings and cosmetic formulation patents. Both describe the exact tripeptide sequence (Gly-His-Lys) chelated to a copper(II) ion. A naturally occurring complex first isolated from human plasma in 1973 by Dr. Loren Pickart. The rest of this article covers the specific biochemical structure, why multiple names exist for the same molecule, how purity verification works regardless of the label, and what naming errors actually indicate about supplier competence.

The Biochemical Identity of GHK Copper Peptide and GHK-Cu

The tripeptide GHK (glycyl-L-histidyl-L-lysine) has no biological activity without the copper ion. The complex only forms when the peptide's histidine residue coordinates with Cu²⁺ through its imidazole nitrogen. This chelation is what distinguishes GHK-Cu from free GHK peptide, which is essentially inert in tissue repair contexts. The copper ion's redox activity is central to the compound's mechanism: it participates in electron transfer reactions that regulate matrix metalloproteinases (MMPs) and stimulate collagen synthesis through TGF-β pathway modulation.

When researchers specify 'GHK Copper Peptide' in a material request, they're describing the same coordination complex as 'GHK-Cu'. The copper is bound to the histidine and lysine residues through nitrogen coordination bonds. The stoichiometry is fixed at 1:1 (one copper ion per peptide molecule), and the resulting complex has a characteristic blue color in solution at concentrations above 1 mM. Suppliers who list both names separately on different product pages are either duplicating catalog entries or demonstrating a fundamental misunderstanding of peptide chemistry. Neither is a good sign.

The biological half-life of GHK-Cu in plasma is approximately 30 minutes in vivo, after which it's cleaved by peptidases or the copper dissociates and rechelates with serum albumin. This short half-life is why research protocols typically use repeated dosing or sustained-release formulations rather than single bolus injections. The peptide sequence itself (Gly-His-Lys) is highly conserved. Changing a single amino acid abolishes copper binding and eliminates biological activity, which is why precise amino acid sequencing during synthesis is non-negotiable for research-grade material.

Our synthesis process at Real Peptides uses solid-phase peptide synthesis (SPPS) with Fmoc chemistry to ensure exact amino acid sequence fidelity. Every batch undergoes HPLC and mass spectrometry verification before copper complexation. The copper is added post-synthesis as copper(II) chloride or copper(II) sulfate in controlled stoichiometric ratios, and the resulting GHK-Cu complex is lyophilized to stable powder form. Whether the final label reads 'GHK Copper Peptide' or 'GHK-Cu', the molecular structure verified by our quality control is identical.

Why Multiple Names Exist for the Same Compound

The naming split between GHK Copper Peptide and GHK-Cu arose from different research communities adopting different notation conventions in the 1970s and 1980s. Early wound healing literature used 'GHK-Cu' because biochemists favored abbreviated amino acid codes (standard practice in protein chemistry), while cosmetic and dermatology publications preferred 'Copper Peptide' or 'GHK Copper Peptide' to emphasize the copper ion's role in collagen remodeling. Both naming systems co-exist in modern research. PubMed searches for either term return overlapping study sets, and regulatory filings with the FDA or EMA use both interchangeably depending on the investigator's field.

The confusion intensifies when suppliers add trademarked or proprietary names to the mix. Commercial formulations sometimes label the compound as 'Copper Tripeptide-1' (INCI nomenclature used in cosmetic ingredient declarations) or use brand names that obscure the underlying molecule entirely. These are still GHK-Cu. The INCI system simply requires a different naming format for ingredient labels. Researchers ordering from suppliers who don't clarify these equivalencies waste time cross-referencing CAS numbers (49557-75-7 for the complex) to confirm they're purchasing the correct compound.

Another source of naming variation: some suppliers distinguish between 'GHK' (the free peptide) and 'GHK-Cu' (the copper complex), which is chemically accurate but leads to confusion when 'GHK Copper Peptide' is used to describe either form depending on context. The free peptide without copper has minimal biological activity in tissue repair assays. Studies published in the Journal of Biological Chemistry found that GHK alone showed less than 10% of the collagen-stimulating activity of GHK-Cu in fibroblast cultures. When a product is labeled 'GHK Copper Peptide', it should always mean the copper-complexed form. But without explicit copper content verification on the certificate of analysis, there's no guarantee.

We include copper content analysis on every GHK CU Copper Peptide batch we ship, verified by inductively coupled plasma mass spectrometry (ICP-MS) to confirm 1:1 peptide-to-copper stoichiometry. If a supplier can't provide copper quantification data, the 'Copper Peptide' label is unverified marketing language. Not a quality assurance standard.

GHK Copper Peptide Same as GHK-Cu: Formulation Comparison

Before ordering any peptide for research, cross-reference the molecular weight, CAS number, and copper content specification to confirm the supplier is delivering the compound the literature describes. The table below compares the standard identity markers for GHK-Cu regardless of which name appears on the label.

Key Takeaways

• GHK Copper Peptide and GHK-Cu are the same molecule. A tripeptide (Gly-His-Lys) chelated to a copper(II) ion with molecular weight ~404 Da and CAS number 49557-75-7.
• The naming split arose from different research fields using different notation conventions. Biochemists favor 'GHK-Cu' while dermatology and cosmetic literature often uses 'GHK Copper Peptide' or 'Copper Tripeptide-1'.
• Free GHK peptide without copper has less than 10% of the biological activity of the copper-complexed form in collagen synthesis assays. Verifying copper content is essential.
• Suppliers listing both names as separate products are either duplicating catalog entries or lack understanding of peptide chemistry. Request CAS number clarification before ordering.
• Every research-grade batch should include HPLC purity verification, mass spectrometry confirmation, and ICP-MS copper quantification. Labels matter less than analytical data.

What If: GHK Copper Peptide Same as GHK-Cu Scenarios

What If a Supplier Lists GHK and GHK-Cu as Separate Products at Different Prices?

Request the certificate of analysis (CoA) for both listings and compare the molecular weight, amino acid sequence, and copper content. If both CoAs show identical specifications (molecular weight ~404 Da, 1:1 copper stoichiometry, same CAS number), they're the same compound and the price difference is arbitrary catalog segmentation. Order whichever is less expensive. If the 'GHK' listing shows molecular weight ~340 Da with no copper content data, it's the free peptide (not the copper complex) and won't deliver the tissue repair activity documented in the literature.

What If the Product Label Says 'GHK Copper Peptide' But the CoA Only Lists 'GHK'?

This indicates incomplete or incorrect documentation. The CoA should explicitly state copper content (typically 15–16% by mass) and molecular weight (~404 Da for the complex vs ~340 Da for free peptide). Contact the supplier and request ICP-MS copper quantification data. If they can't provide it, the product may be free GHK peptide mislabeled as the copper complex, which happens more often than it should when suppliers source peptides from secondary manufacturers without independent verification.

What If Research Protocols Reference 'GHK-Cu' But Only 'Copper Peptide' Products Are Available?

Verify the CAS number (49557-75-7) and molecular weight (~404 Da) on the product specification sheet. If both match, the products are equivalent regardless of naming. Most peer-reviewed studies use 'GHK-Cu' in methods sections but the compounds used were often sourced from cosmetic-grade suppliers labeling them as 'Copper Peptide'. The critical variable is purity and copper stoichiometry verification, not the name on the bottle. Our GHK CU Cosmetic 5MG formulation is the same GHK-Cu complex used in published collagen synthesis studies. The 'cosmetic' label refers to common use case, not a different molecular structure.

What If a Publication Cites 'GHK' Without Specifying Copper Complexation?

Check the methods section for copper salt additions or buffer compositions containing Cu²⁺. Many studies abbreviate 'GHK-Cu' to 'GHK' in results sections after defining it once in methods. If no copper is mentioned and the study shows significant collagen stimulation or MMP modulation, the authors likely used GHK-Cu but abbreviated it inconsistently (common in older dermatology literature). If replicating the study, assume GHK-Cu unless the methods explicitly state 'copper-free' or 'metal-free' peptide. Free GHK alone doesn't replicate the published bioactivity.

The Precise Truth About GHK Copper Peptide and GHK-Cu

Here's the honest answer: if a supplier can't immediately confirm that GHK Copper Peptide and GHK-Cu are the same compound, that supplier doesn't understand peptide chemistry well enough to be synthesizing or distributing research-grade material. This isn't a subtle technical distinction. It's a basic nomenclature equivalence that anyone handling copper-peptide complexes should know by default. The confusion exists because cosmetic ingredient suppliers adopted 'Copper Peptide' branding in the 1990s to make the compound sound more consumer-friendly, while biochemistry labs kept using the standard amino acid abbreviation 'GHK-Cu'. Both names describe the exact same molecule.

The verification that matters isn't the name. It's the analytical data. A legitimate research-grade GHK-Cu product includes HPLC chromatograms showing >95% purity, mass spectrometry confirming molecular weight within 0.5 Da of the theoretical 404 Da, and ICP-MS data quantifying copper content at 15.5–16.0% by mass (the stoichiometric expectation for 1:1 complexation). If any of those three data points are missing from the certificate of analysis, the product's identity is unverified regardless of whether it's labeled 'GHK-Cu', 'GHK Copper Peptide', or 'Copper Tripeptide-1'. We've reviewed supplier CoAs that listed impressive-sounding names but provided zero copper quantification. Which means there's no proof the copper is actually bound to the peptide rather than present as a separate contaminant.

The bottom line: demand the analytical proof, not the marketing label. Every peptide we ship includes the three-point verification standard. HPLC purity, mass spec identity confirmation, and copper stoichiometry by ICP-MS. That's what proves molecular identity, not the product name.

Researchers designing tissue repair studies or collagen remodeling protocols shouldn't waste time debating nomenclature. Verify the CAS number (49557-75-7), confirm the molecular weight (~404 Da), and request copper content data before placing an order. If a supplier lists GHK Copper Peptide and GHK-Cu as separate catalog entries without clarifying they're identical, request a direct explanation or source from a supplier with clearer technical documentation. The compound's biological activity depends on proper copper complexation, not which name appears on the label. Analytical rigor matters. Naming convention does not.